Jacqueline Haim v. HHS - HPV, multiple sclerosis (MS) (2025)

On January 29, 2015, Jacqueline Haim filed a Vaccine Program petition after receiving hepatitis A, human papillomavirus (HPV), and meningococcal meningitis (Menactra) vaccines on July 19, 2013. She alleged that those vaccinations caused or significantly aggravated multiple sclerosis and that residual effects lasted more than six months.

The public decision was entered on a joint stipulation after a long-running case. It identifies the vaccines, the alleged multiple sclerosis theory, and the settlement terms, but it does not describe symptom onset, diagnostic studies, treatment, expert reports, or the litigation history in detail.

Respondent denied that Haim's alleged MS or residual effects were caused in fact or significantly aggravated by the hepatitis A, HPV, or Menactra vaccines, and denied that those vaccines caused any other injury or her current condition. The parties filed a joint stipulation on February 24, 2025.

Special Master Mindy Michaels Roth adopted it the same day and awarded a lump sum of $20,000.00, to be paid by ACH to counsel's IOLTA account for prompt disbursement to Jacqueline Haim. The amount represented all damages available under section 15(a).

Haim was represented by Alexander Laufer of Eisenhower and Laufer, PC.